# Brookdale Senior Living Inc.: overview

BKD · NYSE · CIK 1332349 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bkd.md) · [Financials](/companies/bkd/financials.md) · [Filings](/companies/bkd/filings.md) · [Insiders](/companies/bkd/insiders.md)

Latest reported revenue: [$718.6m](/filings/0001332349-26-000064.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001332349-26-000064).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [784](/filings/0001332349-25-000143.md) | [781 d](/filings/0001332349-26-000032.md) | [814](/filings/0001332349-26-000048.md) | [813](/filings/0001332349-26-000064.md) | [813](/filings/0001332349-25-000143.md) | [754 d](/filings/0001332349-26-000032.md) | [765](/filings/0001332349-26-000048.md) | [719](/filings/0001332349-26-000064.md) |
| Gross margin | % | [25.3%](/filings/0001332349-25-000143.md) | [24.6% d](/filings/0001332349-26-000032.md) | [27.4%](/filings/0001332349-26-000048.md) | [26.6%](/filings/0001332349-26-000064.md) | [25.9%](/filings/0001332349-25-000143.md) | [24.9% d](/filings/0001332349-26-000032.md) | [28.3%](/filings/0001332349-26-000048.md) | [28.6%](/filings/0001332349-26-000064.md) |
| Operating margin | % | [1.3%](/filings/0001332349-25-000143.md) | [(0.3%) d](/filings/0001332349-26-000032.md) | [3.6%](/filings/0001332349-26-000048.md) | [1.8%](/filings/0001332349-26-000064.md) | [(6.6%)](/filings/0001332349-25-000143.md) | [3.0% d](/filings/0001332349-26-000032.md) | [6.8%](/filings/0001332349-26-000048.md) | [11.9%](/filings/0001332349-26-000064.md) |
| Net margin | % | [(6.5%)](/filings/0001332349-25-000143.md) | [(10.7%) d](/filings/0001332349-26-000032.md) | [(8.0%)](/filings/0001332349-26-000048.md) | [(5.3%)](/filings/0001332349-26-000064.md) | [(14.1%)](/filings/0001332349-25-000143.md) | [(5.3%) d](/filings/0001332349-26-000032.md) | [(0.9%)](/filings/0001332349-26-000048.md) | [3.2%](/filings/0001332349-26-000064.md) |
| Diluted EPS | $ per share | [(0.22)](/filings/0001332349-25-000143.md) | not reported | [(0.28)](/filings/0001332349-26-000048.md) | [(0.18)](/filings/0001332349-26-000064.md) | [(0.48)](/filings/0001332349-25-000143.md) | not reported | [(0.03)](/filings/0001332349-26-000048.md) | [0.10](/filings/0001332349-26-000064.md) |
| Free cash flow | $m | [11.5 d](/filings/0001332349-25-000143.md) | [(5.1) d](/filings/0001332349-26-000032.md) | [(18.4)](/filings/0001332349-26-000048.md) | [29.1 d](/filings/0001332349-26-000064.md) | [34.9 d](/filings/0001332349-25-000143.md) | [(29.1) d](/filings/0001332349-26-000032.md) | [(25.6)](/filings/0001332349-26-000048.md) | [43.5 d](/filings/0001332349-26-000064.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,758](/filings/0001332349-24-000041.md) | [2,825](/filings/0001332349-25-000037.md) | [3,016](/filings/0001332349-26-000032.md) | [3,125](/filings/0001332349-26-000032.md) | [3,194](/filings/0001332349-26-000032.md) |
| Gross margin | % | [18.2%](/filings/0001332349-24-000041.md) | [21.0%](/filings/0001332349-25-000037.md) | [24.8%](/filings/0001332349-26-000032.md) | [25.6%](/filings/0001332349-26-000032.md) | [26.2%](/filings/0001332349-26-000032.md) |
| Operating margin | % | [(7.9%)](/filings/0001332349-24-000041.md) | [(1.5%)](/filings/0001332349-25-000037.md) | [0.6%](/filings/0001332349-26-000032.md) | [1.5%](/filings/0001332349-26-000032.md) | [0.4%](/filings/0001332349-26-000032.md) |
| Net margin | % | [(3.6%)](/filings/0001332349-24-000041.md) | [(8.4%)](/filings/0001332349-25-000037.md) | [(6.3%)](/filings/0001332349-26-000032.md) | [(6.5%)](/filings/0001332349-26-000032.md) | [(8.2%)](/filings/0001332349-26-000032.md) |
| Diluted EPS | $ per share | [(0.54)](/filings/0001332349-24-000041.md) | [(1.25)](/filings/0001332349-25-000037.md) | [(0.84)](/filings/0001332349-26-000032.md) | [(0.89)](/filings/0001332349-26-000032.md) | [(1.12)](/filings/0001332349-26-000032.md) |
| Free cash flow | $m | [(271)](/filings/0001332349-24-000041.md) | [(194)](/filings/0001332349-25-000037.md) | [(70.3)](/filings/0001332349-26-000032.md) | [(35.1)](/filings/0001332349-26-000032.md) | [16.5](/filings/0001332349-26-000032.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bkd/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $380.5m | 23,648,712 |  | Added +932,074 |
| [WCM INVESTMENT MANAGEMENT, LLC](/funds/1061186.md) | 2026-06-30 | $229.2m | 14,453,030 |  | Added +1,641,026 |
| [DEERFIELD MANAGEMENT COMPANY, L.P.](/funds/1009258.md) | 2026-06-30 | $187.2m | 11,637,032 |  | Unchanged |
| [ANTIPODES PARTNERS Ltd](/funds/1652442.md) | 2026-06-30 | $178.5m | 11,091,757 |  | Reduced −315,057 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $174.1m | 10,817,723 |  | Added +426,879 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $164.0m | 10,189,802 |  | Added +86,192 |
| [CARRONADE CAPITAL MANAGEMENT, LP](/funds/1866872.md) | 2026-06-30 | $158.9m | 9,878,207 |  | Added +1,291,333 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $155.0m | 9,633,343 |  | Added +802,736 |
| [Maple Rock Capital Partners Inc.](/funds/1658363.md) | 2026-06-30 | $143.0m | 8,888,148 |  | Added +731,000 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $111.9m | 6,954,249 |  | Added +509,070 |

## Recent filings

[All 1,536 filings](/companies/bkd/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-08 | 20:19 ET | [8-K](/filings/0001332349-26-000068.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001332349-26-000068 |
| 2026-08-10 | 20:21 ET | [10-Q](/filings/0001332349-26-000064.md) | Quarterly report, period 2026-06-30 | 0001332349-26-000064 |
| 2026-08-10 | 20:18 ET | [8-K](/filings/0001332349-26-000062.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001332349-26-000062 |
| 2026-07-09 | 20:18 ET | [8-K](/filings/0001332349-26-000057.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001332349-26-000057 |
| 2026-06-24 | 20:22 ET | [8-K](/filings/0001332349-26-000052.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure | 0001332349-26-000052 |
| 2026-05-07 | 20:21 ET | [10-Q](/filings/0001332349-26-000048.md) | Quarterly report, period 2026-03-31 | 0001332349-26-000048 |
| 2026-05-06 | 20:19 ET | [8-K](/filings/0001332349-26-000045.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001332349-26-000045 |
| 2026-04-30 | 20:21 ET | [DEF 14A](/filings/0001193125-26-197412.md) | Proxy statement, period 2026-06-22 | 0001193125-26-197412 |
| 2026-04-20 | 20:18 ET | [8-K](/filings/0001332349-26-000042.md) | 5.02 Departure or appointment of officers or directors | 0001332349-26-000042 |
| 2026-04-08 | 20:17 ET | [8-K](/filings/0001332349-26-000040.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001332349-26-000040 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001332349-26-000032.md), filed Feb 19, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1332349
- Tickers: BKD
- Exchange: NYSE
- SIC code: 8050 Services-Nursing & Personal Care Facilities
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.